EFFECT OF ANTI-AGREGANTS ON THE FUNCTIONAL CONDITION OF ENDOTHELIUM IN CHILDREN OF TEENAGES WITH METABOLIC SYNDROME
Surveyed 42 adolescents with metabolic syndrome. 16 patients received 3 months for dipyridamole treatment. It has been shown that the use of antiplatelet agents (dipyridamole) in the complex therapy of the metabolic syndrome in adolescent children improves the functional state of the endothelium.